Frontiers in Cardiovascular Medicine is a multidisciplinary journal publishing research articles in basic, translational, and clinical cardiovascular medicine. The journal goes beyond current research to anticipate and explore the future of cardiovascular medicine, thus better preventing cardiovascular diseases and improving patient treatment choices and outcomes.
CAS Quartile: Q3
Subcategory: Cardiovascular and Cardiac Systems
JCR Quartile: Q2 Cardiovascular and Hematological Systems (43/143)
Impact Factor: Frontiers in Cardiovascular Medicine, founded in 2014, achieved its first impact factor in 2019. Although its latest impact factor, 5.8+, declined slightly compared with the previous year, its impact still maintained. Among the 143 journals in the same field, this journal ranked 43rd.
The annual publication volume of Frontiers in Cardiovascular Medicine has seen a significant increase, with 175, 333 and 1950 in 2019-2021 respectively, since its accelerating growth and expansion since last year. The proportion of reviews is very large, and the self-citation rate is only 5.8%, keeping within a safe range.
Publication ranking by countries: Frontiers in Cardiovascular Medicine is friendly to Chinese people. In the past three years, the top three countries in terms of the number of articles published are mainland China (1109 articles), the United States (550 articles), and the United Kingdom (188 articles) .
Frontiers in Cardiovascular Medicine accepts diverse types of articles, among which review papers account for a large proportion. According to its official website, the review process will go through two stages: independent review and interactive collaborative review. The average time from submission to final decision is 61 days, which is relatively fast.